Lelli N. CO34 | Developing a scalable model for genetic analysis of extra-myeloid tissues to resolve somatic-germline ambiguity in myeloid disorders: <a href="https://haematologica.org/search/search?query=N.+Lelli">N. Lelli</a>¹, <a href="https://haematologica.org/search/search?query=E.+Ricci">E. Ricci</a>¹, <a href="https://haematologica.org/search/search?query=G.+Silvestrini">G. Silvestrini</a>¹, <a href="https://haematologica.org/search/search?query=E.+Fabiani">E. Fabiani</a>¹, <a href="https://haematologica.org/search/search?query=E.+Marchionni">E. Marchionni</a>², <a href="https://haematologica.org/search/search?query=G.+Ranucci">G. Ranucci</a>¹, <a href="https://haematologica.org/search/search?query=V.+Ferradini">V. Ferradini</a>², <a href="https://haematologica.org/search/search?query=C.+Minotti">C. Minotti</a>^1|2, <a href="https://haematologica.org/search/search?query=S.+Gastaldi">S. Gastaldi</a>^1|2, <a href="https://haematologica.org/search/search?query=G.+D’+Ortenzi">G. D’ Ortenzi</a>^1|2, <a href="https://haematologica.org/search/search?query=C.+Page">C. Page</a>¹, <a href="https://haematologica.org/search/search?query=C.+Di+Raimondo">C. Di Raimondo</a>³, <a href="https://haematologica.org/search/search?query=P.+Ricci">P. Ricci</a>¹, <a href="https://haematologica.org/search/search?query=E.+Lumia">E. Lumia</a>^1|4, <a href="https://haematologica.org/search/search?query=E.+Santinelli">E. Santinelli</a>^4|5, <a href="https://haematologica.org/search/search?query=T.+Ottone">T. Ottone</a>¹, <a href="https://haematologica.org/search/search?query=G.+Novelli">G. Novelli</a>^1|2, <a href="https://haematologica.org/search/search?query=F.+Sangiuolo">F. Sangiuolo</a>^1|2, <a href="https://haematologica.org/search/search?query=C.+Gurnari">C. Gurnari</a>¹, <a href="https://haematologica.org/search/search?query=E.+Attardi">E. Attardi</a>¹, <a href="https://haematologica.org/search/search?query=M.T.+Voso">M.T. Voso</a>¹ | <i>¹Department of Biomedicine and Prevention, University of Rome Tor Vergata; ²Medical Genetics Unit, Policlinico Tor Vergata, University of Rome Tor Vergata; ³Dermatology Unit, Policlinico Tor Vergata; ⁴Department of Biomedicine and Prevention, PhD program in immunology, molecular medicine, and applied biotechnologies, University of Rome Tor Vergata; ⁵Fondazione Policlinico Universitario Campus Bio-Medico</i&gt;. haematol [Internet]. 2026Mar.3 [cited 2026Mar.4];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.43